Sight Sciences Q2 EPS $(0.30) Beats $(0.34) Estimate, Sales $23.47M Beat $22.40M Estimate
Portfolio Pulse from totan@benzinga.com
Sight Sciences (NASDAQ:SGHT) reported Q2 losses of $(0.30) per share, beating the analyst consensus estimate of $(0.34) by 11.76%. This is a 40% increase over losses from the same period last year. The company also reported quarterly sales of $23.47 million, beating the analyst consensus estimate of $22.40 million by 4.78%. This is a 36.23% increase over sales from the same period last year.
August 04, 2023 | 2:28 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Sight Sciences reported better than expected Q2 results with both EPS and sales beating estimates. The company's losses per share improved by 40% YoY and sales increased by 36.23% YoY.
Sight Sciences reported better than expected Q2 results, with both EPS and sales beating estimates. This indicates a strong financial performance, which is likely to have a positive impact on the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100